BG Medicine Inc (BGMD) financial statements (2022 and earlier)

Company profile

Business Address 880 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,5254,1237,75112,786
Cash and cash equivalents1,5254,1237,75112,786
Restricted cash and investments   390
Receivables181174319395
Inventory, net of allowances, customer advances and progress billings145400459447
Inventory145400459447
Prepaid expense 250250
Prepaid expense and other current assets558
Other undisclosed current assets100(96)56 
Total current assets:1,9514,8518,83514,576
Noncurrent Assets
Property, plant and equipment11117192197
Intangible assets, net (including goodwill)77135192372
Intangible assets, net (excluding goodwill)77135192372
Investments and other noncurrent assets13496
Other undisclosed noncurrent assets94126  
Total noncurrent assets:182378518665
TOTAL ASSETS:2,1335,2299,35315,241
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9031,9723,2585,435
Accounts payable5586959651,110
Accrued liabilities3459061,9933,549
Employee-related liabilities 149300776
Interest and dividends payable 222  
Debt 2,9604,3533,245
Deferred revenue and credits250   
Other liabilities271839143
Other undisclosed current liabilities (371)(300)(508)
Total current liabilities:1,1804,5797,3508,315
Noncurrent Liabilities
Long-term debt and lease obligation  2,9616,612
Long-term debt, excluding current maturities  2,9616,612
Liabilities, other than long-term debt335931115
Deferred revenue and credits229   
Other liabilities106931115
Total noncurrent liabilities:335933,0726,617
Total liabilities:1,5154,67210,42214,932
Temporary equity, carrying amount2,594   
Stockholders' equity
Stockholders' equity attributable to parent(1,976)557(1,069)309
Common stock11342821
Additional paid in capital164,318161,525151,841137,377
Accumulated deficit(166,305)(161,002)(152,938)(137,089)
Total stockholders' equity:(1,976)557(1,069)309
TOTAL LIABILITIES AND EQUITY:2,1335,2299,35315,241

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
1,5662,7874,0732,815
Cost of revenue
(Cost of Goods and Services Sold)
(505)(956)(1,389)(957)
Gross profit:1,0611,8312,6841,858
Operating expenses(5,691)(9,250)(17,185)(24,586)
Other undisclosed operating income 57127 
Operating loss:(4,630)(7,362)(14,374)(22,728)
Nonoperating income (expense)(514)262242
Investment income, nonoperating 21522
Other nonoperating income (expense)(514)24720
Interest and debt expense(159)(728)(1,168)(1,083)
Net loss:(5,303)(8,064)(15,520)(23,769)
Other undisclosed net loss attributable to parent  (329) 
Net loss attributable to parent:(5,303)(8,064)(15,849)(23,769)
Preferred stock dividends and other adjustments(1,655)   
Net loss available to common stockholders, diluted:(6,958)(8,064)(15,849)(23,769)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(5,303)(8,064)(15,520)(23,769)
Comprehensive loss, net of tax, attributable to parent:(5,303)(8,064)(15,520)(23,769)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: